Patent · US Active

Radiolabeled drug

US10960089B2 · kind B2 · utility

0Cited by

0References

8Claims

0Family size

Assignee

NATIONAL UNIVERSITY CORPORATION CHIBA UNIVERSITY · JP

Inventors

Yasushi Arano · 小川町, JP
Tomoya Uehara · Shizuoka, JP

Key dates

Filing date	Feb 28, 2017
Grant date	Mar 30, 2021
Priority date	—
Expiry date	Feb 28, 2037

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described are: [1] a compound represented by the formula (1), [2] a compound containing the compound according to [1] and a target molecule recognition element bonded thereto, [3] a metal complex compound containing one kind of a metal selected from a radioactive metal and a radioactive atom-labeled metal, and the compound according to [1] or [2], which is coordinated to the metal, [4] a drug for preparing a radiolabeled drug, containing the compound according to [1] or [2], [5] use of the compound according to [1] or [2], for producing a radiolabeled drug, [6] a radiolabeled drug containing the metal complex compound according to [3], and [7] a radiodiagnostic imaging agent containing the metal complex compound according to [3]:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.